Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fang Du

Showing results (541-550 of 550) with videos related to

Pageof 55
Sort By:
You have reached the last page of results.This site can display upto 550 results.
Arthritis and Rheumatism|July 1, 2009
Multicenter, randomized, double-blind, controlled trial of treatment of active rheumatoid arthritis with T-614 compared with methotrexateLiang-Jing Lu, Chun-de Bao, Min Dai, et al.
Molecular Therapy. Methods & Clinical Development|September 13, 2021
Depletion of high-content CD14<sup>+</sup> cells from apheresis products is critical for successful transduction and expansion of CAR T cells during large-scale cGMP manufacturingXiuyan Wang, Oriana Borquez-Ojeda, Jolanta Stefanski, et al.
Thyroid : Official Journal of the American Thyroid Association|December 6, 2012
RET proto-oncogene genetic screening of families with multiple endocrine neoplasia type 2 optimizes diagnostic and clinical management in ChinaXiao-Ping Qi, Xiao-Ling Chen, Ju-Ming Ma, et al.
Gene|December 26, 2012
Genetic diagnosis of autosomal dominant polycystic kidney disease by targeted capture and next-generation sequencing: utility and limitationsXiao-Ping Qi, Zhen-Fang Du, Ju-Ming Ma, et al.
Elife|August 25, 2022
A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variantsJing Zhang, Zi Bo Han, Yu Liang, et al.
Nature Medicine|January 4, 2022
Lentiviral globin gene therapy with reduced-intensity conditioning in adults with β-thalassemia: a phase 1 trialFarid Boulad, Aurelio Maggio, Xiuyan Wang, et al.
Nature|April 24, 2025
BMAL1-HIF2A heterodimer modulates circadian variations of myocardial injuryWei Ruan, Tao Li, In Hyuk Bang, et al.
Cell Discovery|February 16, 2022
Design of a mutation-integrated trimeric RBD with broad protection against SARS-CoV-2Yu Liang, Jing Zhang, Run Yu Yuan, et al.
Nature Communications|June 27, 2022
Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized phase 2 trialNawal Al Kaabi, Yun Kai Yang, Li Fang Du, et al.
Signal Transduction and Targeted Therapy|January 3, 2023
Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trialNawal Al Kaabi, Yun Kai Yang, Yu Liang, et al.
Pageof 55

Showing results (541-550 of 550) with videos related to

Sort By:
Pageof 55
You have reached the last page of results.This site can display upto 550 results.
Arthritis and Rheumatism|July 1, 2009
Multicenter, randomized, double-blind, controlled trial of treatment of active rheumatoid arthritis with T-614 compared with methotrexateLiang-Jing Lu, Chun-de Bao, Min Dai, et al.
Molecular Therapy. Methods & Clinical Development|September 13, 2021
Depletion of high-content CD14<sup>+</sup> cells from apheresis products is critical for successful transduction and expansion of CAR T cells during large-scale cGMP manufacturingXiuyan Wang, Oriana Borquez-Ojeda, Jolanta Stefanski, et al.
Thyroid : Official Journal of the American Thyroid Association|December 6, 2012
RET proto-oncogene genetic screening of families with multiple endocrine neoplasia type 2 optimizes diagnostic and clinical management in ChinaXiao-Ping Qi, Xiao-Ling Chen, Ju-Ming Ma, et al.
Gene|December 26, 2012
Genetic diagnosis of autosomal dominant polycystic kidney disease by targeted capture and next-generation sequencing: utility and limitationsXiao-Ping Qi, Zhen-Fang Du, Ju-Ming Ma, et al.
Elife|August 25, 2022
A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variantsJing Zhang, Zi Bo Han, Yu Liang, et al.
Nature Medicine|January 4, 2022
Lentiviral globin gene therapy with reduced-intensity conditioning in adults with β-thalassemia: a phase 1 trialFarid Boulad, Aurelio Maggio, Xiuyan Wang, et al.
Nature|April 24, 2025
BMAL1-HIF2A heterodimer modulates circadian variations of myocardial injuryWei Ruan, Tao Li, In Hyuk Bang, et al.
Cell Discovery|February 16, 2022
Design of a mutation-integrated trimeric RBD with broad protection against SARS-CoV-2Yu Liang, Jing Zhang, Run Yu Yuan, et al.
Nature Communications|June 27, 2022
Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized phase 2 trialNawal Al Kaabi, Yun Kai Yang, Li Fang Du, et al.
Signal Transduction and Targeted Therapy|January 3, 2023
Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trialNawal Al Kaabi, Yun Kai Yang, Yu Liang, et al.
Pageof 55